Status:
TERMINATED
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Lead Sponsor:
David Haines, MD
Collaborating Sponsors:
Medtronic BRC
Conditions:
Cardiac Arrest
Sudden Cardiac Death
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this research study is to evaluate the effectiveness of metoprolol, a "beta blocker," in treating patients in the hospital with a cardiac arrest. It will be given intravenously (given i...
Detailed Description
Sudden cardiac death (SCD) is a catastrophic event and most commonly results from acute ventricular tachyarrhythmias (abnormal and lethal heart rhythms). It is often triggered by acute coronary events...
Eligibility Criteria
Inclusion
- All patients age \> 18 years of age who develop an in-hospital VF or pVT arrest which persists after three or more precordial shocks.
- Patients who develop an in-hospital cardiac arrest due to asystole or PEA which subsequently converts to VF or pVT will be included.
Exclusion
- Pediatric patients
- Pregnancy
- Age \< 18 years of age
- Patients who develop VF or pVT in the emergency room, operating room or surgical intensive care unit.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00401882
Start Date
January 1 2007
End Date
March 1 2012
Last Update
May 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073